Translational Development Acquisition Corp. (TDAC) stock
TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
$10.88+0.01 (+0.10%)
Close on Nov 18, 2026Market cap $210.09MP/E –Yield –
Translational Development Acquisition operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Translational Development Acquisition's operating income for the twelve months ending Jun 30, 2026 was -$1.32M. For fiscal 2025 it was -$944.54K.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$944.54K | – |
| FY2024 | Dec 31, 2024 | -$196.36K | – |
| FY2023 | Dec 31, 2023 | -$485.55K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$661.05K | – |
| Q1 FY2026 | Mar 31, 2026 | -$281.16K | – |
| Q4 FY2025 | Dec 31, 2025 | -$162.35K | – |
| Q3 FY2025 | Sep 30, 2025 | -$213.66K | – |
| Q2 FY2025 | Jun 30, 2025 | -$221.13K | – |
| Q1 FY2025 | Mar 31, 2025 | -$347.41K | – |
| Q4 FY2024 | Dec 31, 2024 | -$133.39K | – |
| Q3 FY2024 | Sep 30, 2024 | -$61.28K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.69K | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
See a number that looks wrong?